Interview of Michael Chan for RTHK
- May 12, 2021
- 1 min read
RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID19.
top of page
bottom of page
RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID19.
